Sprout Pharmaceuticals to market female libido pill

Raleigh-based Sprout Pharmaceuticals has received FDA approval to market its ADDYI (flibanserin) pill to treat hypoactive sexual desire disorder in premenopausal women. CEO Cindy Whitehead elaborates on her new small pharma company's efforts to p
Up Next
Raleigh-based Sprout Pharmaceuticals has received FDA approval to market its ADDYI (flibanserin) pill to treat hypoactive sexual desire disorder in premenopausal women. CEO Cindy Whitehead elaborates on her new small pharma company's efforts to p

Valeant acquiring Raleigh-based Sprout for $1 billion

August 20, 2015 09:39 AM